RxDoctor Payments Data

Hannah Miller

Physician Assistant · Farmington Hills, MINPI 1225659196

Payments from drug & device makers

$2,099in general payments, 2019–2025

Across 44 payments — averaging $47.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$414
  • AstraZeneca$378
  • Seagen Inc.$289
  • AbbVie$258
  • Eisai Inc.$146
  • Karyopharm Therapeutics Inc.$140
  • plus $474 from 6 others

What the payments were for

  • Food & beverage$2,099100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,099 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$4,420
Medicare patients
20
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LynparzaOlaparib45$662,407
ZejulaNiraparib Tosylate12$212,447
EliquisApixaban39$25,204
Anastrozole23$1,123
Prochlorperazine Maleate32$667
Potassium Chloride31$645
Ondansetron Hcl43$547
Dexamethasone78$509
Pantoprazole Sodium25$382
Metronidazole15$306
Letrozole14$152
Gabapentin19$130
Oxycodone Hcl13$95
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$74
Prednisone22$28

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaLynparza$378$662,40745 claims
GSKZejula$130$212,44712 claims
PfizerEliquis$49$25,20439 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Farmington Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →